Cerebral ischemic damage and inflammatory reaction

Chinese Pharmacological Bulletin

Volumn 22, Issue 1, 2006, Pages 5-9

  Zhang, Yu Yang ^a   Liu, Yan ^a   Fu, Shou Ting ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Arachidonic acid; Bradykinin; Cytokine; Ischemia; Leukocyte; Mast cells

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ARTICLE; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; ENCEPHALITIS; HUMAN; LEUKOCYTE; MAST CELL; NONHUMAN;

EID: 33646194788     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ritter LS, Orozeo JA, Coull BM et al. Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke[J]. Stroke, 2000, 31(5): 1153-61.
2. Steiner DR, Gonzalez NC, Wood JG. Mast cells mediate the microvascular inflammatory response to systemic hypoxia[J]. J Appl Physiol, 2003, 94(1): 325-34.
3. Michaloudi H, Grivas I, Batzios C et al. Parallel development of blood vessels and mast cells in the lateral geniculate nuclei[J]. Dev Brain Res, 2003, 140(2): 269-76.
4. Schielke GP, Yang GY, Silverstein FS et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage[J]. J Cereb Blood Flow Meteb, 1999, 19 (10):1099-108.
5. Savitz SI, Erhardt JA, Anthony JV et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke[J]. J Cereb Blood Flow Metab, 2000, 20(8):1197-204.
6. Ma XC, Gottschall PE, Chen LT et al. Role and mechanisms of interleukin-1 in the modulation of neurotoxicity[J]. Neuroimmunomodulation, 2002-2003, 10(4):199-207.
7. Gong C, Qin Z, Betz AL et al. Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice[J]. Brain Res. 1998, 801(1-2):1-8.
8. Peng Q, Wei Z, Lau BH. Pyenogenol inhibits turner necrosis factor-alpha-induced nuclear kappa B activation and adhesion molecule expression in human vascular endothelial cells[J]. Cell Mol Life Sci, 2000, 47(5): 834-42.
9. Clark WM, Rinker LG, Lessov NS et al. Time course of IL-6 expression in experimental CNS ischemia[J]. Neurol Res, 1999, 21 (3): 287-92
10. Loddick SA, Turnbull AV, Rothwell NJ et al. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J]. J Cereb Blood Flow Metab, 1998, 18(2):176-9.
11. Vila N, Castillo J, Davalos A et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J]. Stroke, 2000, 31(10): 2325-9.
12. Aihara M, Ishii S, Kume K et al. Interaction between neurone and microglia mediated by platelet-activating factor[J]. Genes Cells. 2000, 5(5): 397-406.
13. Park TS, Gonzales ER, Gidday JM. Platelet activating factor mediates ischemia-induced leukocyte endothelial adherence in newborn pig brain[J]. J Cereb Blood Flow Metab, 1999, 19(4): 417 -24.
14. 1 on cerebral blood flow in patients with chronic cerebral infarction[J]. Inter Med, 1998, 37(10): 841-6.
15. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock inflammation and ischemia/reperfusion injury[J]. Eur J Pharmacol, 2001, 426(1-2):1-10.
16. Ciceri P, Rabuffetti M, Monopoli A et al. Production of leukotrienes in a model of focal cerebral ischemia in the rat[J]. Br J Pharmacol, 2001, 133(8):1323-9.
17. Zhang WP, Wei EQ, Mei RH et al. Neuroprotective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in rats [J]. Acta Pharm Sin, 2002, 23(10): 871-7.
18. Wagner S, Kalb P, Lukosava M et al. Activation of the tissue kallikrein-kinin system in stroke[J]. J Neurol Sci, 2002, 202(1-2): 75-6.
19. Sarker MH, Hu DE, Freser PA. Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat[J]. J Physiol, 2000, 528(1):177-87.
20. 2 receptor antagonist, reduces ischaemic brain injury in a murine model of transient focal cerebral ischaemia[J]. Br J Pharmacol, 2003, 139(10):1539-47.